如何在持续肾脏替代治疗期间延长滤器使用寿命？
How to Prolong Filter Life During Continuous Renal Replacement Therapy?
作者信息
Tsujimoto Yasushi, Fujii Tomoko
机构信息
Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan.
出版信息
Crit Care. 2022 Mar 22;26(1):62. doi: 10.1186/s13054-022-03910-8.
Abstract
This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .
摘要
本文是从《重症监护与急诊医学年度进展2022》中选出的十篇综述之一。其他入选文章可在https://www.biomedcentral.com/collections/annualupdate2022在线查阅。有关《重症监护与急诊医学年度进展》的更多信息可从https://link.springer.com/bookseries/8901获取。
相似文献
1
How to Prolong Filter Life During Continuous Renal Replacement Therapy?如何在持续肾脏替代治疗期间延长滤器使用寿命？
Crit Care. 2022 Mar 22;26(1):62. doi: 10.1186/s13054-022-03910-8.
2
Advanced Life Support Update.高级生命支持更新。
Crit Care. 2022 Mar 22;26(1):73. doi: 10.1186/s13054-022-03912-6.
3
Artificial Intelligence in Critical Care Medicine.重症医学中的人工智能
Crit Care. 2022 Mar 22;26(1):75. doi: 10.1186/s13054-022-03915-3.
4
The Importance of Neuromonitoring in Non Brain Injured Patients.神经监测在非脑损伤患者中的重要性。
Crit Care. 2022 Mar 22;26(1):78. doi: 10.1186/s13054-022-03914-4.
5
Artificial Intelligence in Infection Management in the ICU.人工智能在 ICU 感染管理中的应用。
Crit Care. 2022 Mar 22;26(1):79. doi: 10.1186/s13054-022-03916-2.
6
Sepsis Performance Improvement Programs: From Evidence Toward Clinical Implementation.脓毒症绩效改进计划：从证据到临床实施
Crit Care. 2022 Mar 22;26(1):77. doi: 10.1186/s13054-022-03917-1.
7
The Role of Mitochondria in the Immune Response in Critical Illness.线粒体在危重症免疫反应中的作用
Crit Care. 2022 Mar 22;26(1):80. doi: 10.1186/s13054-022-03908-2.
8
Immunomodulation by Tetracyclines in the Critically Ill: An Emerging Treatment Option?四环素对危重症患者的免疫调节作用：一种新兴的治疗选择？
Crit Care. 2022 Mar 22;26(1):74. doi: 10.1186/s13054-022-03909-1.
9
Brain Injury Biomarkers for Predicting Outcome After Cardiac Arrest.用于预测心脏骤停后预后的脑损伤生物标志物。
Crit Care. 2022 Mar 22;26(1):81. doi: 10.1186/s13054-022-03913-5.
10
Vasopressor Choice and Timing in Vasodilatory Shock.血管扩张性休克中血管活性药物的选择与时机
Crit Care. 2022 Mar 22;26(1):76. doi: 10.1186/s13054-022-03911-7.
引用本文的文献
1
Effects of different blood flow rates on filter and circuit life in non-anticoagulation CRRT: Protocol for a three-arm, single-blind randomized controlled trial (the Flow-CRRT Study).不同血流速率对非抗凝连续性肾脏替代治疗中滤器及管路寿命的影响：一项三臂、单盲随机对照试验方案（血流-连续性肾脏替代治疗研究）
PLoS One. 2025 Aug 22;20(8):e0330845. doi: 10.1371/journal.pone.0330845. eCollection 2025.
2
Interruptions and downtime of continuous renal replacement therapy in critically ill adults: A retrospective observational study.危重症成年患者连续性肾脏替代治疗的中断与停机时间：一项回顾性观察研究。
Nurs Crit Care. 2025 Mar;30(2):e13265. doi: 10.1111/nicc.13265.
3
Optimizing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation: Insights from the ORCA Trial-A Retrospective Study on 10 Years of Practice.优化局部枸橼酸抗凝的连续性肾脏替代治疗：来自ORCA试验的见解——一项基于10年实践的回顾性研究
Life (Basel). 2024 Oct 14;14(10):1304. doi: 10.3390/life14101304.
4
How to safeguard the continuous renal replacement therapy circuit: a narrative review.如何保障连续性肾脏替代治疗回路：一篇叙述性综述
Front Med (Lausanne). 2024 Aug 21;11:1442065. doi: 10.3389/fmed.2024.1442065. eCollection 2024.
5
Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.危重症患者连续性肾脏替代治疗的抗凝选择：系统评价和网络荟萃分析的随机对照试验。
Crit Care. 2023 Jun 7;27(1):222. doi: 10.1186/s13054-023-04519-1.
6
Regional Citrate Anticoagulation or Heparin Anticoagulation for Renal Replacement Therapy in Patients With Liver Failure: A Systematic Review and Meta-Analysis.肝功能衰竭患者肾脏替代治疗中局部枸橼酸抗凝或肝素抗凝的系统评价和荟萃分析。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231174001. doi: 10.1177/10760296231174001.
本文引用的文献
1
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.非药物干预措施预防连续性肾脏替代治疗中体外循环凝血。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD013330. doi: 10.1002/14651858.CD013330.pub2.
2
Low Blood Flow Continuous Veno-Venous Haemodialysis Compared with Higher Blood Flow Continuous Veno-Venous Haemodiafiltration: Effect on Alarm Rates, Filter Life, and Azotaemic Control.低血流连续静脉-静脉血液透析与高血流连续静脉-静脉血液透析滤过的比较：对报警率、滤器寿命和氮质血症控制的影响。
Blood Purif. 2022;51(2):130-137. doi: 10.1159/000516146. Epub 2021 May 19.
3
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. Reply.急性肾损伤中肾脏替代治疗开始的时机。回复
N Engl J Med. 2020 Oct 29;383(18):1797-1798. doi: 10.1056/NEJMc2027489.
4
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.局部枸橼酸抗凝与全身肝素抗凝对连续性肾脏替代治疗中急性肾损伤危重症患者透析滤器寿命和死亡率的影响：一项随机临床试验。
JAMA. 2020 Oct 27;324(16):1629-1639. doi: 10.1001/jama.2020.18618.
5
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.肾功能与疾病的命名：改善全球肾脏病预后组织（KDIGO）共识会议报告
Kidney Int. 2020 Jun;97(6):1117-1129. doi: 10.1016/j.kint.2020.02.010. Epub 2020 Mar 9.
6
Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.连续肾脏替代治疗期间预防体外循环凝血的药理学干预措施。
Cochrane Database Syst Rev. 2020 Mar 13;3(3):CD012467. doi: 10.1002/14651858.CD012467.pub2.
7
Diagnosis, management, and prognosis of patients with acute kidney injury in Japanese intensive care units: The JAKID study.日本重症监护病房急性肾损伤患者的诊断、治疗和预后：JAKID 研究。
J Crit Care. 2018 Oct;47:185-191. doi: 10.1016/j.jcrc.2018.07.007. Epub 2018 Jul 6.
8
Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation.接受局部枸橼酸盐抗凝持续肾脏替代治疗的危重症患者的高乳酸血症、乳酸动力学及枸橼酸盐蓄积预测
Crit Care Med. 2017 Sep;45(9):e941-e946. doi: 10.1097/CCM.0000000000002501.
9
Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit.重症监护病房肾脏替代治疗的启动策略。
N Engl J Med. 2016 Jul 14;375(2):122-33. doi: 10.1056/NEJMoa1603017. Epub 2016 May 15.
10
Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial.甲磺酸萘莫司他作为高出血风险患者持续肾脏替代治疗期间的抗凝剂：一项随机临床试验。
Medicine (Baltimore). 2015 Dec;94(52):e2392. doi: 10.1097/MD.0000000000002392.
Zotero 插件